Department of Pharmacy Practice

Dr. Kumar is a tenure-track Assistant Professor of Pharmaceutics at the University of Toledo, Department of Pharmacy Practice. His research focuses on developing nanoformulations for small and large molecules to treat liver fibrosis (nonalcoholic, and alcoholic liver fibrosis) and cancers (medulloblastoma, pancreatic, and melanoma). Specific research areas I have focused on include manipulating the Biodistribution, Pharmacokinetics, and Metabolism of small molecules and biologics using nanoformulations for different diseases. Bioanalytical assay development for small and large molecules using UPLC-MS/MS and HRMS. Further, his special interest is in developing various disease models including tumors (orthotopic pancreatic cancer, medulloblastoma, glioblastoma, melanoma, AML, and HCC), liver disease (NAFLD, NASH, ALD, cholestatic liver fibrosis, and partial hepatectomy), and organ injury model (traumatic brain injury, kidney, and lung injury model) in small animals (mice, rat, guinea pig).

 

He applies strong drug discovery and pharmaceutics principles considering the most recent advancements in biology and material sciences to tackle challenging medical and drug delivery concerns. His research is funded by two grants from the National Institutes of Health (NIH) as a PI: an R21 from 2023 to 2025 and a K01 (Mentored Research Scientist Development Award) from 2021 to 2026. In addition, he is also serving as Co-I on three R01 grants from 2024 to 2027.